FzioMed Awarded Patent for Oxiplex Technology in Surgical Adhesion Prevention

FzioMed Inc. (San Luis Obispo, CA) has been issued a fourth patent related to the company's Oxiplex technology.

Oxiplex is a polymer technology that produces bioresorbable materials for a variety of medical applications. The company's goal is to develop a diverse line of Oxiplex products for medical uses such as post-surgical adhesion prevention, osteoarthritis, and drug delivery.

Clinical trials of the company's first product, a bioresorbable Oxiplex film for adhesion prevention in laparoscopic surgery, are underway in the United States. FzioMed had developed the FilmSert instrument, a tool designed to deliver Oxiplex film products in a laparoscopic surgical procedure. The company is also developing gel formulations of Oxiplex for potential use in both adhesion prevention and osteoarthritis.